Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
A table highlighting the key messages by NICE when dealing with statin-related adverse effects
| Advice and Monitoring for Adverse Effects | Recommendations | 
|---|---|
| Advise people on statins | • Potential interactions with other drugs/foods/supplements • Consult pharmacist/prescriber for advice • Restart statin if stopped due to interactions or intercurrent illnesses | 
| Before offering a statin | • Ask about muscle symptoms history • if associated or not with previous lipid-lowering therapy • if they have ➡️ measure creatine kinase levels | 
| Muscle symptoms and creatine kinase levels | • >5 times upper limit measure CK after 7 days if CK levels are still 5 times ULN ➡️ Do not start statin ❌ • Raised but <5 times: ✅Start at a lower dose | 
| Risk of muscle adverse effects | • Low risk of muscle pain, tenderness, weakness is small • Extremely low risk of severe effects ( rhabdomyolysis ) | 
| Unexplained muscle symptoms | • Advise seeking medical advice • Measure creatine kinase if this happens | 
| Muscle symptoms with normal creatine kinase | • Reassure unlikely due to statin, explore other causes • If they report muscle pain, tenderness or weakness and CK is < 5 times ULN -reassure that symptoms are unlikely due to statins | 
| Asymptomatic individuals on statins | • No... | 
Try our Free Plan to get the full article.